You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
Presenters at ASM have used next-generation sequencing to examine Ebola, Zika, and respiratory virus infection and transmission.
The tool has been applied to determine the pathogenic cause of hemorrhagic fever, and is powering a new test for respiratory disease pathogens.
In Nature this week: reverse genetics used to gauge phenotypes of loss-of-function mutations, and more.
The virus spread according to a gravity model between large population centers, and its movements were affected by geographical distance.
In Genome Biology this week: epigenetic differences in CML cells, predicting aggressive prostate cancer, and more.
An international team of researchers examined differential gene expression in blood samples from patients infected during the West African outbreak.
In Cell this week: Ebola virus improved ability to infect humans during recent outbreak, and more.
The Ebola virus may have mutated to better infect humans during the 2014 outbreak, the New York Times reports.
US Army scientists have developed a way to more precisely determine the amount of antigen needed as they develop an Ebola virus-like particle vaccine.
In PLOS this week: cell-free DNA from tumors is shorter than DNA from healthy cells, type 2 diabetes-related loci, and more.
The Washington Post reports on researchers' efforts to determine the effect of an increasingly common SARS-CoV-2 mutation.
Florida Politics reports Florida's law barring life, long-term care, and disability insurers from using genetic information in coverage decisions went into effect at the beginning of July.
A new analysis finds a link between popular media coverage of a scientific study and how often that paper is cited.
In Nature this week: CRISPR approaches to editing plant genomes, way to speed up DNA-PAINT, and more.